-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS - ARO-MAPT GENERALLY WELL TOLERATED, MOST ADVERSE EVENTS MILD, NO SERIOUS TEAES REPORTED

Reuters·10/14/2026 11:33:18